Cyclophilin D-mediated regulation of the permeability transition pore is altered in mice lacking the mitochondrial calcium uniporter.
Animals
Calcium
/ metabolism
Calcium Channels
/ deficiency
Cyclophilins
/ genetics
Disease Models, Animal
Humans
Induced Pluripotent Stem Cells
/ metabolism
Mice, Knockout
Mitochondria, Heart
/ drug effects
Mitochondrial Membrane Transport Proteins
/ metabolism
Mitochondrial Permeability Transition Pore
Mitochondrial Proteins
/ deficiency
Myocardial Infarction
/ enzymology
Myocardial Reperfusion Injury
/ enzymology
Myocardium
/ enzymology
Phosphorylation
Receptor-Interacting Protein Serine-Threonine Kinases
/ deficiency
Signal Transduction
Journal
Cardiovascular research
ISSN: 1755-3245
Titre abrégé: Cardiovasc Res
Pays: England
ID NLM: 0077427
Informations de publication
Date de publication:
01 02 2019
01 02 2019
Historique:
received:
22
03
2018
accepted:
22
08
2018
pubmed:
31
8
2018
medline:
7
3
2020
entrez:
31
8
2018
Statut:
ppublish
Résumé
Knockout (KO) of the mitochondrial Ca2+ uniporter (MCU) in mice abrogates mitochondrial Ca2+ uptake and permeability transition pore (PTP) opening. However, hearts from global MCU-KO mice are not protected from ischaemic injury. We aimed to investigate whether adaptive alterations occur in cell death signalling pathways in the hearts of global MCU-KO mice. First, we examined whether cell death may occur via an upregulation in necroptosis in MCU-KO mice. However, our results show that neither RIP1 inhibition nor RIP3 knockout afford protection against ischaemia-reperfusion injury in MCU-KO as in wildtype (WT) hearts, indicating that the lack of protection cannot be explained by upregulation of necroptosis. Instead, we have identified alterations in cyclophilin D (CypD) signalling in MCU-KO hearts. In the presence of a calcium ionophore, MCU-KO mitochondria take up calcium and do undergo PTP opening. Furthermore, PTP opening in MCU-KO mitochondria has a lower calcium retention capacity (CRC), suggesting that the calcium sensitivity of PTP is higher. Phosphoproteomics identified an increase in phosphorylation of CypD-S42 in MCU-KO. We investigated the interaction of CypD with the putative PTP component ATP synthase and identified an approximately 50% increase in this interaction in MCU-KO cardiac mitochondria. Mutation of the novel CypD phosphorylation site S42 to a phosphomimic reduced CRC, increased CypD-ATP synthase interaction by approximately 50%, and increased cell death in comparison to a phospho-resistant mutant. Taken together these data suggest that MCU-KO mitochondria exhibit an increase in phosphorylation of CypD-S42 which decreases PTP calcium sensitivity thus allowing activation of PTP in the absence of an MCU-mediated increase in matrix calcium.
Identifiants
pubmed: 30165576
pii: 5079902
doi: 10.1093/cvr/cvy218
pmc: PMC6657279
doi:
Substances chimiques
Calcium Channels
0
Mcu protein, mouse
0
Mitochondrial Membrane Transport Proteins
0
Mitochondrial Permeability Transition Pore
0
Mitochondrial Proteins
0
Receptor-Interacting Protein Serine-Threonine Kinases
EC 2.7.11.1
Ripk3 protein, mouse
EC 2.7.11.1
Cyclophilins
EC 5.2.1.-
PPID protein, human
EC 5.2.1.8
Calcium
SY7Q814VUP
Types de publication
Journal Article
Research Support, N.I.H., Intramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
385-394Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL142589
Pays : United States
Organisme : NHLBI NIH HHS
ID : ZIA HL002066
Pays : United States
Commentaires et corrections
Type : CommentIn
Références
J Physiol. 2017 Jun 15;595(12):3743-3751
pubmed: 27991671
Cardiovasc Res. 2014 Jul 15;103(2):206-16
pubmed: 24920296
Annu Rev Physiol. 2007;69:51-67
pubmed: 17007587
J Proteome Res. 2009 Oct;8(10):4665-75
pubmed: 19694452
J Natl Cancer Inst. 2015 Feb 03;107(3):
pubmed: 25650317
Cell Rep. 2015 Jul 7;12(1):15-22
pubmed: 26119742
Nature. 2005 Mar 31;434(7033):658-62
pubmed: 15800627
J Biol Chem. 1997 Aug 22;272(34):21104-12
pubmed: 9261114
J Biol Chem. 2010 Mar 26;285(13):9535-44
pubmed: 20042608
J Exp Med. 2000 Oct 2;192(7):1001-14
pubmed: 11015441
Mol Cell Biol. 2004 Feb;24(4):1464-9
pubmed: 14749364
J Biol Chem. 2014 Jun 6;289(23):15980-5
pubmed: 24790105
J Mol Cell Cardiol. 2015 Aug;85:178-82
pubmed: 26057074
J Biol Chem. 2011 Nov 18;286(46):40184-92
pubmed: 21930693
Cardiovasc Res. 1993 Oct;27(10):1790-4
pubmed: 8275525
Cell Death Differ. 2016 Jan;23(1):1-2
pubmed: 26586571
Proc Natl Acad Sci U S A. 2015 Jul 21;112(29):9129-34
pubmed: 26153425
Biophys J. 2001 Dec;81(6):3275-84
pubmed: 11720991
Nat Rev Mol Cell Biol. 2014 Feb;15(2):135-47
pubmed: 24452471
Nat Cell Biol. 2018 Feb;20(2):186-197
pubmed: 29358703
PLoS One. 2015 Jun 10;10(6):e0130520
pubmed: 26061004
Proc Natl Acad Sci U S A. 2010 Jan 12;107(2):726-31
pubmed: 20080742
Nature. 2011 Jun 19;476(7360):336-40
pubmed: 21685888
J Mol Cell Cardiol. 1993 Dec;25(12):1461-9
pubmed: 7512654
Nat Cell Biol. 2013 Dec;15(12):1464-72
pubmed: 24212091
Biochemistry. 2012 Apr 10;51(14):2959-73
pubmed: 22443365
Biochim Biophys Acta. 2009 Dec;1787(12):1486-91
pubmed: 19616504
Stem Cells Transl Med. 2017 Feb;6(2):527-538
pubmed: 28191759
Arch Biochem Biophys. 1979 Jul;195(2):453-9
pubmed: 383019
Nat Med. 2016 Feb;22(2):175-82
pubmed: 26726877
Sci Rep. 2015 Jun 11;5:11319
pubmed: 26066579
Proc Natl Acad Sci U S A. 2013 Jul 16;110(29):12024-9
pubmed: 23818611
Aging (Albany NY). 2010 Dec;2(12):914-23
pubmed: 21212461
Nature. 2011 Jun 19;476(7360):341-5
pubmed: 21685886
J Biol Chem. 2009 Dec 4;284(49):33982-8
pubmed: 19801635
Cell Rep. 2015 Jul 7;12(1):23-34
pubmed: 26119731
FEBS Lett. 2002 Feb 13;512(1-3):1-7
pubmed: 11852041